GBA Presents: RADIO SAVANT-!

TESLA BOTTOMED AGAIN TODAY TED !!! :D
HF SAYS IT'S A GO-! HOLD FOR 1 YEAR<----------------------

IRA ALERT))))))))))))))))))))))))))))))))))))TSLA

WE IN THIS MORNING NOT SURE WHERE A FEW BUCKS OFF LOW!!!!

gba upgrade TSLA!!!!!:caution:
 
stonedinvestor said:
GlycoMimetics, Inc. (GLYC)- Ted I believe you were looking at this.
NasdaqGM - Nasdaq GM Real Time Price.
2.9100-0.1200(-3.96%)/

Chart Events
logo-18-18.svg

Bullishpattern detected
generic.svg

MACD
More...



GlycoMimetics, Inc. (GLYC)- DO WE LIKE OR NOT?
NasdaqGM - NasdaqGM Real Time Price.
2.7950+0.1950(+7.50%)
As of 02:37PM EST.

 
JUST SOME HOUSEKEEPING HERE.
WAY BACK IN MARCH WE BOUGHT AEROJET ALL OVER IN MANY ACCOUNTS-AND I HAVE FORGOTTEN --
THESE GUYS GOT BOUGHT OUT IT'S DEAD MONEY JUST SITTING IN IRA'S-!

Aerojet Rocketdyne Holdings,

39.13-0.14(-0.36%) <-- I think it's a buy here
As of 12:32PM EDT.

#373 Mar 21, 2022 Report
Reply Share



Aerojet Rocketdyne Holdings, Inc. (AJRD)
NYSE - Nasdaq Real Time Price. Currency in USD

55.91-0.18(-0.32%)<----------------- RAISE CASH!
As of 02:55PM EST.
 
Last edited:
H.C. Wainwright bullish on Esperion as CLEAR Outcomes meets primary endpoint 12/07 ESPR H.C. Wainwright analyst Joseph Pantginis notes that Esperion has announced its Phase 3 CLEAR Outcomes trial evaluating NEXLETOL met its primary endpoint. Patients experienced a statistically significant risk reduction in MACE-4 after administration of 180 mg/day NEXLETOL compared to placebo. Pantginis expects the announcement to have a positive impact on the stock ahead of the full data, though could see increased volatility in the interim as investors weigh the news. He looks forward to the data at a major medical conference in Q1 2023. The analyst reiterates a Buy rating on the shares with a price target of $22.

;)
 
You must log in or register to reply here.
Back
Top